Abstract
A library of diarylurea insulin-like growth factor 1 receptor inhibitors was screened for activity against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of Plasmodium falciparum. The 4-aminoquinaldine-derived diarylureas displayed promising antimalarial potency. Further exploration of the B ring of 4-aminoquinaldinyl ureas allowed identification of several quinaldin-4-yl ureas 4{13, 39} and 4{13, 58} sufficiently potent against both 3D7 and K1 strains to qualify as bone fide leads.
Original language | English |
---|---|
Pages (from-to) | 460-465 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 1 |
Issue number | 9 |
DOIs | |
State | Published - Dec 9 2010 |
Keywords
- Malaria
- diarylurea
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry